Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of the Touro College & University System, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to Scholarly Communications Librarian Carrie Levinson.

Total number of publications: 7,256

Enter a faculty name:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

First Prev 1 2 3 4 5 6 7 8 9 Next Last
  • Akhondzadeh, S., Gerbarg, P. L., & Brown, R. P. (2013). Nutrients for prevention and treatment of mental health disorders. Psychiatric Clinics of North America, 36(1), 25-36. doi:10.1016/j.psc.2012.12.003

  • Aquila, R., & Citrome, L. (2015). Cognitive impairment in schizophrenia: The great unmet need. CNS Spectrums, 20(Suppl 1), 32-40. doi:10.1017/S109285291500070X

  • Arbuckle, M. R., Weinberg, M., Barkil-Oteo, A., Stern, D. A., Ranz, J. M., & Mental Health Services Committee of the Group for the Advancement of Psychiatry. (2014). The neglected role of resource manager in residency training. Academic Psychiatry:The Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, 38(4), 481-484. doi:10.1007/s40596-014-0136-5

  • Barkil-Oteo, A., Stern, D. A., & Arbuckle, M. R. (2014). Addressing the cost of health care from the front lines of psychiatry. JAMA Psychiatry, 71(6), 619-620. doi:10.1001/jamapsychiatry.2014.121

  • Battisti, W. P., Wager, E., Baltzer, L., Bridges, D., Cairns, A., Carswell, C. I., . . . Citrome, L. (2015). Good publication practice for communicating company-sponsored medical research: GPP3. Annals of Internal Medicine, 163(6), 461-464. doi:10.7326/M15-0288

  • Billick, S. B., & Garakani, A. (2014). Ophthalmologic screening in 25 consecutive geriatric psychiatric inpatient admissions. The Psychiatric Quarterly, 85(1), 49-56. doi:10.1007/s11126-013-9269-z

  • Billick, S. B., Martell, D. A. (2013). Forensic psychiatry and forensic psychology. In D. H. Ubelaker (Ed.), Forensic science: Current issues, future directions (pp. 211-223). Chichester, England: Wiley-Blackwell.

  • Brown, R. P., Gerbarg, P. L. & Muench, F. (2013). Breathing practices for treatment of psychiatric and stress-related medical conditions. Psychiatric Clinics of North America, 36(1), 121-40. doi:10.1016/j.psc.2013.01.001

  • Bulbena-Cabre, A., H. P., Dunn, N. R., & Swift, R. G. (2015). "Crack lung": A pulmonary complication of crack cocaine case. Journal of Addiction Medicine, 9(2), 164-165. doi:10.1097/ADM.0000000000000102

  • Bulbena-Cabre, A., H. P., Dunn, N. R., & Swift, R. G. (2015). Cyclobenzaprine-induced hallucinosis. The Primary Care Companion for CNS Disorders, 17(3), e1. doi:10.4088/PCC.14l01773

  • Bush, R.. (2016). Understanding eating disorders in gay men. Behavioral Health News, 4(1), 23-30. This material can be found here.

  • Castro, J., & Billick, S. B. (2013). Psychiatric presentations/manifestations of medical illness. The Psychiatric Quarterly, 84(3), 351-362. doi:10.1007/s11126-012-9251-1

  • Castro, J., Billick, S. B., & Swank, A. C. (2016). Utility of a new Spanish RQC and PSC in screening with CBCL validation. The Psychiatric Quarterly, 87(2), 343-353. doi:10.1007/s11126-015-9391-1

  • Castro, J., Billick, S. B., Kleiman, A., Chiechi, M., & Al-Rashdan, M. (2014). Confounding psychosis in the postpartum period. The Psychiatric Quarterly, 85(1), 91-96. doi:10.1007/s11126-013-9271-5

  • Citrome, L. (2013). A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: An evidence-based medicine approach. CNS Drugs, 27(11), 879-911. doi:10.1007/s40263-013-0105-7

  • Citrome, L. (2013). Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: Focus on inhaled loxapine as an alternative to injectable agents. Therapeutics and Clinical Risk Management, 9, 235-245. doi:10.2147/TCRM.S31484

  • Citrome, L. (2013). Cariprazine: Chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability. Expert Opinion on Drug Metabolism and Toxicology, 9(2), 193-206. doi:10.1517/17425255.2013.759211

  • Citrome, L. (2013). Cariprazine in bipolar disorder: Clinical efficacy, tolerability, and place in therapy. Advances in Therapy, 30(2), 102-113. doi:10.1007/s12325-013-0004-9

  • Citrome, L. (2013). Cariprazine in schizophrenia: Clinical efficacy, tolerability, and place in therapy. Advances in Therapy, 30(2), 114-126. doi:10.1007/s12325-013-0006-7

  • Citrome, L. (2013). Handbook of treatment-resistant schizophrenia. London, England: Springer Healthcare.

  • Citrome, L. (2013). Holiday time! Evidence-based flying revisited. International Journal of Clinical Practice, 67(12), 1213-1214. doi:10.1111/ijcp.12348

  • Citrome, L. (2013). Inhaled loxapine for agitation. Current Psychiatry12(2), 31-36. This material can be found here.

  • Citrome, L. (2013). Levomilnacipran for major depressive disorder: A systematic review of the efficacy and safety profile for this newly approved antidepressant--what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? International Journal of Clinical Practice, 67(11), 1089-1104. doi:10.1111/ijcp.12298

  • Citrome, L. (2013). Meta-analyses: Editor's dream or nightmare? International Journal of Clinical Practice, 67(11), 1069-1070. doi:10.1111/ijcp.12324

  • Citrome, L. (2013). New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia. Expert Review of Neurotherapeutics, 13(7), 767-783. doi:10.1586/14737175.2013.811984

First Prev 1 2 3 4 5 6 7 8 9 Next Last